Back to all cases
Pharmaceutical company (not specified)
🇯🇵 Japan·2022
Collected
DBR
Case Summary
Paved the way for regulatory approval of RWD in Japan.
Source
- Title
- Trajectory for the Regulatory Approval of a Combination of Pertuzumab Plus Trastuzumab for Pre-treated HER2-positive Metastatic Colorectal Cancer Using Real-world Data.
- Type
- academic paper
- Year
- 2022
- Confidence Score
- 80%